{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T09:51:26Z","timestamp":1720000286000},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12886-016-0349-3","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T11:11:49Z","timestamp":1475493109000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment"],"prefix":"10.1186","volume":"16","author":[{"given":"Menelaos G.","family":"Kanakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysanthi","family":"Koutsandrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Georgalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"349_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/00207459408986065","volume":"79","author":"J Korein","year":"1994","unstructured":"Korein J, Sansaricq C, Kalmijn M, Honig J, Lange B. Maple syrup urine disease: clinical, eeg, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Int J Neurosci. 1994;79:21\u201345.","journal-title":"Int J Neurosci"},{"key":"349_CR2","first-page":"12","volume":"14","author":"JP Burke","year":"1991","unstructured":"Burke JP, O\u2019Keefe M, Bowell R, Naughten ER. Ophthalmic findings in maple syrup urine disease. Metab Pediatr Syst Ophthalmol. 1991;14:12\u20135.","journal-title":"Metab Pediatr Syst Ophthalmol"},{"key":"349_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exer.2005.10.031","volume":"83","author":"RMH Diederen","year":"2006","unstructured":"Diederen RMH, La Heij EC, Deutz NEP, Kijlstra A, Kessels AGH, van Eijk HMH, et al. Increased glutamate levels in the vitreous of patients with retinal detachment. Exp Eye Res. 2006;83:45\u201350.","journal-title":"Exp Eye Res"},{"key":"349_CR4","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/clinchem\/34.8.1610","volume":"34","author":"JA Wuu","year":"1988","unstructured":"Wuu JA, Wen LY, Chuang TY, Chang GG. Amino acid concentrations in serum and aqueous humor from subjects with extreme myopia or senile cataract. Clin Chem. 1988;34:1610\u20133.","journal-title":"Clin Chem"},{"key":"349_CR5","first-page":"462","volume":"68","author":"DG Durham","year":"1970","unstructured":"Durham DG. Distribution of free amino acids in human intraocular fluids. Trans Am Ophthalmol Soc. 1970;68:462\u2013500.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"349_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/00006982-200604000-00009","volume":"26","author":"Y Wakabayashi","year":"2006","unstructured":"Wakabayashi Y, Yagihashi T, Kezuka J, Muramatsu D, Usui M, Iwasaki T. Glutamate levels in aqueous humor of patients with retinal artery occlusion. Retina. 2006;26:432\u20136.","journal-title":"Retina"},{"key":"349_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/sj.eye.6702993","volume":"22","author":"KM Bertram","year":"2008","unstructured":"Bertram KM, Bula DV, Pulido JS, Shippy SA, Gautam S, Lu MJ, et al. Amino-acid levels in subretinal and vitreous fluid of patients with retinal detachment. Eye. 2008;22:582\u20139.","journal-title":"Eye"},{"key":"349_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/archopht.121.2.183","volume":"121","author":"RA Honkanen","year":"2003","unstructured":"Honkanen RA, Baruah S, Zimmerman MB, Khanna CL, Weaver YK, Narkiewicz J, et al. Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol. 2003;121:183\u20138.","journal-title":"Arch Ophthalmol"},{"key":"349_CR9","first-page":"611","volume":"77","author":"VM Asensio S\u00e1nchez","year":"2002","unstructured":"Asensio S\u00e1nchez VM, Corral Azor A, Aguirre Arag\u00f3n B, De Paz Garc\u00eda M. Amino acid concentrations in the vitreous body in control subjects. Arch Soc Esp Oftalmol. 2002;77:611\u20136.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"349_CR10","first-page":"1357","volume":"20","author":"O Yalcinbayir","year":"2014","unstructured":"Yalcinbayir O, Buyukuysal RL, Gelisken O, Buyukuysal C, Can B. Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment. Mol Vision. 2014;20:1357\u201365.","journal-title":"Mol Vision"},{"key":"349_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1755-3768.1975.tb01781.x","volume":"53","author":"F Schonheyder","year":"1975","unstructured":"Schonheyder F, Ehlers N, Hust B. Remarks on the aqueous humor\/plasma ratios for amino acids and related compounds in patients with various chronic ocular disorders. Acta Ophthalmol. 1975;53:627\u201334.","journal-title":"Acta Ophthalmol"},{"key":"349_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/IAE.0b013e31816079fb","volume":"28","author":"O Aydemir","year":"2008","unstructured":"Aydemir O, T\u00fcrk\u00e7\u00fco\u01e7lu P, G\u00fcler M, \u00c7eliker \u00dc, \u00dcst\u00fcnda\u01e7 B, Yilmaz T, et al. Plasma and vitreous homocysteine concentrations in patients with proliferative diabetic retinopathy. Retina. 2008;28:741\u20133.","journal-title":"Retina"},{"key":"349_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1750-1172-9-73","volume":"9","author":"KR Vogel","year":"2014","unstructured":"Vogel KR, Arning E, Wasek BL, McPherson S, Bottiglieri T, Gibson KM. Brain\u2013blood amino acid correlates following protein restriction in murine maple syrup urine disease. Orphanet J Rare Dis. 2014;9:73.","journal-title":"Orphanet J Rare Dis"},{"key":"349_CR14","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1167\/iovs.10-6422","volume":"52","author":"RG Hu","year":"2011","unstructured":"Hu RG, Lim JC, Kalloniatis M, Donaldson PJ. Cellular localization of glutamate and glutamine metabolism and transport pathways in the rat ciliary epithelium. Invest Ophthalmol Vis Sci. 2011;52:3345\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"349_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0014-4835(77)90134-8","volume":"25","author":"VN Reddy","year":"1977","unstructured":"Reddy VN, Thompson MR, Chakrapani B. Amino acid transport across blood-aqueous barrier of mammalian species. Exp Eye Res. 1977;25:555\u201362.","journal-title":"Exp Eye Res"},{"key":"349_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0306-3623(76)90014-8","volume":"7","author":"MJ Neal","year":"1976","unstructured":"Neal MJ. Amino acid transmitter substances in the vertebrate retina. Gen Pharmacol. 1976;7:321\u201332.","journal-title":"Gen Pharmacol"},{"key":"349_CR17","first-page":"1361","volume":"99","author":"S Kashii","year":"1995","unstructured":"Kashii S. The role of nitric oxide in the ischemic retina. Nippon Ganka Gakkai Zasshi. 1995;99:1361\u201376.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"349_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0165-6147(90)90129-V","volume":"11","author":"D Nicholls","year":"1990","unstructured":"Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 1990;11:462\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"349_CR19","first-page":"2779","volume":"41","author":"DM Sherry","year":"2000","unstructured":"Sherry DM, Townes-Anderson E. Rapid glutamatergic alterations in the neural retina induced by retinal detachment. Invest Ophthalmol Vis Sci. 2000;41:2779\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"349_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1471-4159.1992.tb09409.x","volume":"59","author":"PR Dodd","year":"1992","unstructured":"Dodd PR, Williams SH, Gundlach AL, Harper PA, Healy PJ, Dennis JA, et al. Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem. 1992;59:582\u201390.","journal-title":"J Neurochem"},{"key":"349_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/brain\/awp024","volume":"132","author":"WJ Zinnanti","year":"2009","unstructured":"Zinnanti WJ, Lazovic J, Griffin K, Skvorak KJ, Paul HS, Homanics GE, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009;132:903\u201318.","journal-title":"Brain"},{"key":"349_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1471-4159.1966.tb05882.x","volume":"13","author":"AL Prensky","year":"1966","unstructured":"Prensky AL, Moser HW. Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem. 1966;13:863\u201374.","journal-title":"J Neurochem"},{"key":"349_CR23","first-page":"2673","volume":"18","author":"H Ripps","year":"2012","unstructured":"Ripps H, Shen W. Review: Taurine: a \u201cvery essential\u201d amino acid. Mol Vision. 2012;18:2673\u201386.","journal-title":"Mol Vision"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0349-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-016-0349-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0349-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T11:07:05Z","timestamp":1601118425000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-016-0349-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1186\/s12886-016-0349-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]},"article-number":"170"}}